USA’s COVID-19 Vaccine Successfully Passed Human Trials

Trials related to the Coronavirus vaccine are going on worldwide, and now their trial results are also coming out. Moderna Inc. is yet another company that is competing in this race. Scientists are happy with the results of the first two trials of the first tested COVID-19 vaccine in the US prepared by this company. Now the final testing of this vaccine will be done. The reports have shown that this vaccine has worked on people’s immune systems exactly as scientists had expected.

American government’s top infectious disease specialist doctor Anthony Fossey told the news agency that no matter how people perceive this information, it is good news. This experimental vaccine is being jointly produced by the National Institutes of Health and Moderna Inc. Its most important and final testing will be done around 27 July.

COVID-19 Vaccine

The results of the first trial of the COVID-19 vaccine, which was conducted on 45 people in March, were eagerly awaited by all researchers. The findings have raised hopes of increasing the immunity of the people by using this vaccine. The research team told the New England Journal of Medicine that these volunteers developed neutralizing antibodies that prevent infection.

Doctor Jackson of the Kaiser Permanente Washington Research Institute in Seattle, who led the study, said, ‘This is an essential link to move forward in trials, which can determine whether this vaccine is capable of protecting us against coronavirus infection or not.”

How long the COVID-19 vaccine will come ultimately can nothing be said about it, but the government is hopeful that its results will come by the end of the year. Efforts are being made to develop this vaccine very fast. Two doses of this vaccine will be given.

No severe side effects of the COVID-19 vaccine have been seen in research. However, more than half of the study participants reported flu-like symptoms, which are commonly seen after all types of vaccines. Among these, it is common to feel tired, headache, chills, fever, and pain at the injection site.